Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine technology: looking to the future.

F Dorner1, P N Barrett

  • 1Biomedical Research Center, Baxter-Immuno, Orth/Donau, Austria.

Annals of Medicine
|April 29, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tick-borne encephalitis vaccines.

Internal medicine journal·2013
Same author

Increasing West Nile virus antibody titres in central European plasma donors from 2006 to 2010.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2011
Same author

Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage.

Cytotechnology·2008
Same author

Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.

Vaccine·2006
Same author

Systematic evaluation of different approaches for minimizing hemodynamic changes during pneumoperitoneum.

Surgical endoscopy·2006
Same author

Cloning, expression and functional characterization of the full-length murine ADAMTS13.

Journal of thrombosis and haemostasis : JTH·2005

Vaccination significantly reduces mortality and controls diseases, but ideal vaccines remain elusive. New technologies like recombinant DNA offer promising advancements in vaccine development for global health.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Biotechnology

Background:

  • Vaccination is a cornerstone of public health, significantly reducing mortality and controlling infectious diseases globally.
  • Despite successes like smallpox eradication, the precise mechanisms of many vaccines are not fully understood.
  • Current vaccine types (live attenuated, inactivated, subunit) have limitations, and an ideal vaccine remains a goal.

Purpose of the Study:

  • To review traditional and novel vaccine development methodologies.
  • To highlight the need for improved vaccines against persistent infectious agents.
  • To explore the potential of new technologies, such as recombinant DNA, in vaccinology.

Main Methods:

  • Review of existing literature on vaccine types and development.

Related Experiment Videos

  • Discussion of traditional vaccine production methods.
  • Exploration of advanced biotechnological approaches, including recombinant DNA technology.

    • Main Results:

    • Traditional vaccine development has limitations in achieving ideal safety and efficacy profiles.
    • New technologies are crucial for overcoming challenges with current vaccines.
    • Recombinant DNA approaches present new avenues for vaccine design and production.

    Conclusions:

    • The development of improved vaccines is a critical objective in biomedical sciences.
    • Novel technologies are essential for creating next-generation vaccines.
    • Advancements in vaccinology promise enhanced control over infectious diseases.